{Etokimab: A Deep Analysis into the 2022981-44-6 Immunoglobulin Etokimab, designated by the specific identifier 2022981-44-6, represents a emerging antibody currently in research evaluation. This medicinal agent, https://www.targetmol.com/compound/etokimab